Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Index benchmarks provide a transparent yardstick for performance, helping investors gauge risk-adjusted returns and make informed choices.
27,627 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
SQQQ has endured sustained daily reset losses that compound over time, erasing most of its value even as the Nasdaq-1...
A fresh risk-off wave hits crypto markets as the VIX climbs past 29, pushing ProShares Ultra Ether ETF (ETHT) and Eth...
Investors are turning to weekly-paying ETFs to craft an ultimate passive income portfolio that aims for steady weekda...
Three sector ETFs are beating the Nasdaq tech index in 2026, signaling a shift toward defense tech, electrification, ...
When a company director buys a sizable stake, investors take notice. This article breaks down the meaning behind the ...
As AI momentum pauses, three AI-driven tech stocks worth buying the dip emerge with signs of improving fundamentals a...
As Bitcoin sits in the current price range, analysts lay out a spectrum of 2030 outcomes. This story unpacking scenar...
As the S&P 500 retreats, two growth-focused ETFs show resilience. This report breaks down why FELG and QQQ are defyin...
UnitedHealth Group has climbed toward its 52-week high, signaling strong investor interest. This article breaks down ...
Geopolitical tensions and stubborn inflation are rattling markets. Even higher-income americans turning cautious sign...
A sharp market pullback followed a bold political statement about the Iran deal. This guide breaks down what happened...